1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with ropivacaine in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (ropivacaine) | Trials (ropivacaine) | Recent Studies (post-2010) (ropivacaine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 3,869 | 1,982 | 1,857 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Tan, Z; Xu, Y; Zhu, M; Zhu, X | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and ropivacaine
| Article | Year |
|---|---|
Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils.
Topics: 1-Butanol; Amides; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; CD11 Antigens; Cell Adhesion; Egtazic Acid; Endothelial Cells; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipase D; Platelet Activating Factor; Ropivacaine; Umbilical Veins | 2010 |